Michael E Dicus, MD
Nephrology · Salinas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 3
Offices
3 locations · Central Coast Nephrology Medical Corporation · County of Monterey
Looking this up.
Hospitals listed: 552713 · 552724 · 552898 · Community Hospital of the Monterey Peninsula · George L Mee Memorial Hospital · Natividad Medical Center · Salinas Valley Health Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dicus’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- Natividad Medical CenterSalinas, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Natividad Medical CenterPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.316, Oct 2024 – Sep 2025
- Salinas Valley Health Medical CenterSalinas, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Salinas Valley Memorial Healthcare SystemPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
- Southern Monterey County Memorial HospitalKing City, CACritical Access Hospital · Voluntary non-profit - Other · Has an emergency department64% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Natividad Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.316 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 332 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.18 (0.76 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.77 (109.76 to 221.78) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 609 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.48) · 2,445 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.36 (2.03 to 6.7) · 564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.44 to 3.71) · 555 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.67 (1.19 to 20.15) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.92 (0.71 to 9.12) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.07 (0.12 to 2.02) · 1,742 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.462 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 62 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.4 · 93 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -7.3 · 121 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.9) · 162 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 72 cases | No different | Jan 2024 – Dec 2024 |
What patients said (966 patients answered, 55% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Salinas Valley Health Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.34 to 2.3) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.68 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.42 (143.23 to 253.6) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (1.83 to 6.1) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.87 to 3.76) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (3.73 to 15.83) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.23 (1.52 to 8.95) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,011 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.487 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.082 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.432 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8 · 660 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 569 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 485 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.2 to 8.4) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 489 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Southern Monterey County Memorial Hospital
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 55 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -10.4 · 25 cases | None | Jul 2022 – Jun 2025 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 94% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 64% |
Original Medicare doctor bills
$679,368
Medicare paid this office $679,368 for 654 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 77 | $148,486 | $283 |
| Injection, denosumab, 1 mg | 43 | $53,092 | None |
| Injection, inclisiran, 1 mg | 12 | $34,931 | None |
| Home dialysis services per month (20 years or older) | 20 | $27,621 | $232 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 54 | $26,441 | $240 |
See all 29 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 77 | $148,486 | $283 |
| Injection, denosumab, 1 mg | 43 | $53,092 | None |
| Injection, inclisiran, 1 mg | 12 | $34,931 | None |
| Home dialysis services per month (20 years or older) | 20 | $27,621 | $232 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 54 | $26,441 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 116 | $13,993 | $62 |
| Short return visit (20+ min) | 95 | $9,070 | $51 |
| Short return visit (20+ min) | 121 | $6,953 | $36 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 19 | $6,531 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $5,259 | $135 |
| Dialysis procedure including 1 evaluation | 17 | $4,559 | $70 |
| Return visit (30+ min) | 47 | $4,060 | $52 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 36 | $3,345 | $54 |
| Short return visit | 89 | $3,182 | $27 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 60 | $2,909 | $38 |
| Injection of drug or substance under skin or into muscle | 85 | $2,353 | $12 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,271 | $103 |
| Administration of chemotherapy into vein, 1 hour or less | 13 | $2,173 | $109 |
| Hemodialysis procedure with physician evaluation | 29 | $1,727 | $56 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 97 | $1,684 | $12 |
| Influenza vaccine split virus, preservative free | 15 | $1,227 | $82 |
| Insertion of needle into vein for collection of blood sample | 62 | $943 | $9 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $878 | $26 |
| New patient visit (15+ min) | 24 | $792 | $33 |
| Kidney function blood test panel | 52 | $715 | $9 |
| Administration of influenza virus vaccine | 20 | $686 | $34 |
| Administration of chemotherapy into vein, each additional hour | 12 | $528 | $23 |
| Red blood cell concentration measurement | 16 | $63 | $2 |
| Blood count, hemoglobin | 16 | $63 | $2 |
Who their Medicare patients are
654 Original Medicare patients in 2024. Average age 70 · Under 65 22% · 85 and older 9% · Women 50% · Also on Medicaid 63% · Health risk score 4.24. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 70% · Heart failure 39% · Coronary heart disease 36% · Atrial fibrillation 25% · Depression 25% · COPD 17% · Stroke 12% · Cancer 10% · Dementia 9%.
The office billed $1,591,446, Medicare allowed $865,102 and paid $679,368; for 37,249 services of 68 kinds; $401,856 of it was for drugs given in the office and $277,512 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 654 | 37,249 | 70 | 4.24 | $1,591,446 | $679,368 |
| 2023 | 759 | 40,518 | 71 | 4.03 | $1,764,661 | $824,005 |
| 2022 | 751 | 34,954 | 72 | 3.45 | $1,491,466 | $728,376 |
| 2021 | 777 | 32,354 | 71 | 3.58 | $1,158,527 | $529,430 |
| 2020 | 788 | 31,469 | 70 | 3.88 | $1,103,776 | $484,777 |
| 2019 | 831 | 32,285 | 70 | 3.89 | $1,497,402 | $633,459 |
| 2018 | 848 | 35,350 | 70 | 4.02 | $1,583,968 | $698,865 |
| 2017 | 865 | 40,069 | 69 | 4.00 | $1,622,602 | $715,570 |
| 2016 | 800 | 18,975 | 69 | 3.99 | $1,367,605 | $620,073 |
| 2015 | 831 | 22,274 | 69 | 4.29 | $1,325,264 | $601,318 |
| 2014 | 791 | 26,034 | 70 | 3.97 | $1,217,004 | $551,459 |
| 2013 | 796 | 32,701 | 69 | 3.97 | $1,149,348 | $518,570 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 34 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 103 | $176,049 | $295 |
| Injection, denosumab, 1 mg | 32 | $36,269 | None |
| Injection, romosozumab-aqqg, 1 mg | 13 | $31,924 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $24,025 | $245 |
| Home dialysis services per month (20 years or older) | 19 | $22,227 | $244 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 183 | $21,862 | $65 |
| Short return visit (20+ min) | 152 | $9,455 | $39 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $8,679 | $142 |
| Short return visit (20+ min) | 79 | $6,847 | $51 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 16 | $5,969 | None |
| Return visit (30+ min) | 59 | $4,723 | $56 |
| Dialysis procedure including 1 evaluation | 18 | $4,107 | $72 |
| Hemodialysis procedure with physician evaluation | 53 | $4,031 | $58 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 15 | $3,730 | $0 |
| Administration of chemotherapy into vein, 1 hour or less | 18 | $3,555 | $119 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 36 | $3,501 | $51 |
| Return visit (30+ min) | 23 | $2,853 | $79 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 58 | $2,850 | $41 |
| Short return visit | 75 | $2,245 | $25 |
| Injection of drug or substance under skin or into muscle | 75 | $1,914 | $12 |
| New patient visit (30+ min) | 22 | $1,369 | $62 |
| Insertion of needle into vein for collection of blood sample | 79 | $1,100 | $8 |
| Administration of chemotherapy into vein, each additional hour | 18 | $1,029 | $25 |
| Influenza vaccine split virus, preservative free | 13 | $1,007 | $72 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $977 | $34 |
| Kidney function blood test panel | 70 | $945 | $9 |
| New patient visit (15+ min) | 26 | $873 | $34 |
| Injection of drug or substance into vein | 15 | $770 | $32 |
| Administration of influenza virus vaccine | 15 | $444 | $28 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $263 | $19 |
| Blood test, comprehensive group of blood chemicals | 11 | $114 | $10 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 13 | $100 | None |
| Blood count, hemoglobin | 17 | $70 | $2 |
| Red blood cell concentration measurement | 17 | $65 | $2 |
2022: 29 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 70 | $133,553 | $309 |
| Injection, denosumab, 1 mg | 29 | $31,612 | None |
| Home dialysis services per month (20 years or older) | 15 | $26,836 | $246 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 192 | $25,152 | $60 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 45 | $12,635 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $11,847 | $165 |
| Short return visit (20+ min) | 143 | $11,014 | $44 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $9,775 | $257 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 22 | $8,993 | $1 |
| Short return visit (20+ min) | 81 | $6,283 | $51 |
| Return visit (30+ min) | 65 | $5,353 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 46 | $4,057 | $56 |
| Hemodialysis procedure with physician evaluation | 43 | $3,810 | $62 |
| Dialysis procedure including 1 evaluation | 16 | $3,796 | $74 |
| Return visit (30+ min) | 26 | $3,738 | $83 |
| Injection of drug or substance under skin or into muscle | 81 | $2,889 | $12 |
| Short return visit | 64 | $2,163 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 41 | $1,742 | $32 |
| New patient visit (15+ min) | 23 | $1,100 | $48 |
| Kidney function blood test panel | 95 | $1,022 | $9 |
| New patient visit (30+ min) | 13 | $794 | $61 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $536 | $23 |
| Insertion of needle into vein for collection of blood sample | 116 | $439 | $3 |
| New patient visit (15+ min) | 14 | $371 | $27 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $310 | $26 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $179 | $15 |
| Hemoglobin a1c level | 13 | $144 | $10 |
| Blood count, hemoglobin | 37 | $136 | $2 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $113 | $8 |
2021: 31 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 69 | $133,158 | $307 |
| Home dialysis services per month (20 years or older) | 19 | $40,242 | $242 |
| Injection, denosumab, 1 mg | 29 | $34,059 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 191 | $25,196 | $60 |
| Short return visit (20+ min) | 148 | $19,046 | $69 |
| Return visit (30+ min) | 76 | $16,673 | $99 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 54 | $15,652 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $14,549 | $169 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $9,000 | $250 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 22 | $8,638 | $1 |
| Short return visit (20+ min) | 57 | $4,968 | $51 |
| Dialysis procedure including 1 evaluation | 16 | $3,924 | $74 |
| Short return visit | 79 | $3,581 | $28 |
| Hemodialysis procedure with physician evaluation | 39 | $3,536 | $62 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 42 | $3,485 | $61 |
| Injection of drug or substance under skin or into muscle | 89 | $3,320 | $12 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $2,462 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,571 | $87 |
| Telephone medical discussion with physician, 5-10 minutes | 27 | $1,520 | $40 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,446 | $69 |
| Return visit (30+ min) | 17 | $1,393 | $73 |
| Kidney function blood test panel | 110 | $1,112 | $9 |
| New patient visit (15+ min) | 19 | $1,017 | $54 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $991 | $50 |
| New patient visit (30+ min) | 17 | $896 | $53 |
| New patient visit (15+ min) | 18 | $711 | $39 |
| Administration of chemotherapy into vein, each additional hour | 11 | $690 | $28 |
| Insertion of needle into vein for collection of blood sample | 131 | $468 | $3 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $422 | $32 |
| Blood count, hemoglobin | 50 | $206 | $2 |
| Blood test, comprehensive group of blood chemicals | 13 | $137 | $11 |
2020: 28 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 107 | $155,363 | $247 |
| Injection, denosumab, 1 mg | 34 | $34,208 | None |
| Home dialysis services per month (20 years or older) | 23 | $28,002 | $204 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 200 | $26,203 | $61 |
| Short return visit (20+ min) | 193 | $16,175 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $16,022 | $169 |
| Return visit (30+ min) | 81 | $12,354 | $83 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 39 | $11,719 | None |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 22 | $9,438 | $1 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $8,103 | $203 |
| Hemodialysis procedure with physician evaluation | 59 | $5,104 | $61 |
| Dialysis procedure including 1 evaluation | 15 | $5,077 | $74 |
| Short return visit (20+ min) | 46 | $3,832 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 39 | $3,298 | $61 |
| Injection of drug or substance under skin or into muscle | 82 | $2,607 | $12 |
| Short return visit | 75 | $1,903 | $18 |
| Telephone medical discussion with physician, 5-10 minutes | 40 | $1,653 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,518 | $89 |
| Short return visit | 34 | $1,340 | $33 |
| Influenza vaccine split virus, preservative free | 21 | $1,220 | $58 |
| Kidney function blood test panel | 110 | $1,191 | $9 |
| New patient visit (30+ min) | 18 | $1,088 | $60 |
| New patient visit (15+ min) | 14 | $866 | $62 |
| Administration of influenza virus vaccine | 33 | $576 | $17 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $468 | $33 |
| Insertion of needle into vein for collection of blood sample | 123 | $462 | $3 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $327 | $17 |
| Blood count, hemoglobin | 37 | $170 | $2 |
2019: 30 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 125 | $168,133 | $229 |
| Home dialysis services per month (20 years or older) | 24 | $33,077 | $189 |
| Short return visit (20+ min) | 257 | $25,760 | $56 |
| Injection, denosumab, 1 mg | 27 | $25,428 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 187 | $23,502 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $14,653 | $167 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 44 | $12,887 | $195 |
| Return visit (30+ min) | 94 | $12,785 | $78 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 43 | $11,766 | None |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 20 | $8,395 | $1 |
| Short return visit (20+ min) | 82 | $7,989 | $40 |
| Hemodialysis procedure with physician evaluation | 74 | $6,501 | $60 |
| Dialysis procedure including 1 evaluation | 11 | $5,027 | $72 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 48 | $4,986 | $62 |
| Administration of chemotherapy into vein, 1 hour or less | 14 | $3,218 | $124 |
| Injection of drug or substance under skin or into muscle | 78 | $2,556 | $14 |
| Complete ultrasound scan behind abdominal cavity | 24 | $2,268 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $1,811 | $82 |
| New patient visit (30+ min) | 26 | $1,578 | $61 |
| New patient visit (15+ min) | 30 | $1,420 | $47 |
| Short return visit | 33 | $1,397 | $34 |
| Kidney function blood test panel | 111 | $1,239 | $9 |
| Administration of chemotherapy into vein, each additional hour | 14 | $980 | $26 |
| Short return visit | 42 | $893 | $20 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 22 | $575 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $531 | $30 |
| Insertion of needle into vein for collection of blood sample | 128 | $447 | $3 |
| Administration of influenza virus vaccine | 22 | $370 | $17 |
| Hemoglobin a1c level | 15 | $169 | $11 |
| Blood count, hemoglobin | 35 | $127 | $3 |
2018: 33 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 150 | $261,162 | $227 |
| Injection, infliximab, excludes biosimilar, 10 mg | 14 | $58,497 | None |
| Injection, denosumab, 1 mg | 48 | $45,451 | None |
| Home dialysis services per month (20 years or older) | 19 | $29,450 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 183 | $22,982 | $58 |
| Short return visit (20+ min) | 196 | $22,331 | $52 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 59 | $17,659 | $188 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 43 | $16,240 | None |
| Return visit (30+ min) | 78 | $14,377 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $9,144 | $163 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 14 | $5,827 | $1 |
| Short return visit (20+ min) | 64 | $5,359 | $36 |
| Hemodialysis procedure with physician evaluation | 70 | $5,293 | $58 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 34 | $3,837 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 16 | $3,377 | $116 |
| Injection of drug or substance under skin or into muscle | 94 | $3,274 | $17 |
| Hospital discharge day management, 30 minutes or less | 43 | $2,590 | $58 |
| Dialysis procedure including 1 evaluation | 15 | $2,396 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,210 | $85 |
| Complete ultrasound scan behind abdominal cavity | 24 | $1,942 | $78 |
| New patient visit (15+ min) | 34 | $1,673 | $49 |
| Short return visit | 48 | $1,632 | $30 |
| Kidney function blood test panel | 106 | $1,346 | $10 |
| Dialysis services, per day, less than full month service (20 years or older) | 14 | $1,222 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 30 | $1,051 | $30 |
| Administration of chemotherapy into vein, each additional hour | 16 | $1,021 | $26 |
| New patient visit (30+ min) | 14 | $625 | $45 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 19 | $448 | $24 |
| Administration of influenza virus vaccine | 20 | $435 | $22 |
| Insertion of needle into vein for collection of blood sample | 113 | $417 | $3 |
| Short return visit | 18 | $318 | $17 |
| Blood count, hemoglobin | 42 | $158 | $3 |
| Urinalysis, manual test | 11 | $35 | $3 |
2017: 28 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 168 | $279,322 | $221 |
| Injection, denosumab, 1 mg | 46 | $40,465 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 117 | $36,579 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 216 | $27,606 | $56 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 41 | $25,475 | None |
| Short return visit (20+ min) | 212 | $21,654 | $49 |
| Home dialysis services per month (20 years or older) | 12 | $17,082 | $180 |
| Return visit (30+ min) | 73 | $15,184 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $12,115 | $159 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 17 | $7,346 | $1 |
| Hemodialysis procedure with physician evaluation | 70 | $6,263 | $57 |
| Short return visit (20+ min) | 68 | $5,156 | $34 |
| Injection of drug or substance under skin or into muscle | 90 | $5,072 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 45 | $4,389 | $55 |
| Complete ultrasound scan behind abdominal cavity | 27 | $2,327 | $83 |
| Hospital discharge day management, 30 minutes or less | 36 | $2,185 | $58 |
| New patient visit (15+ min) | 44 | $1,793 | $41 |
| Dialysis procedure including 1 evaluation | 11 | $1,561 | $68 |
| Short return visit | 46 | $1,533 | $29 |
| Dialysis services, per day, less than full month service (20 years or older) | 19 | $1,346 | $6 |
| Kidney function blood test panel | 82 | $1,155 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $955 | $31 |
| Administration of influenza virus vaccine | 21 | $565 | $27 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 21 | $392 | $19 |
| Insertion of needle into vein for collection of blood sample | 94 | $333 | $3 |
| Hemoglobin a1c level | 11 | $183 | $13 |
| Blood count, hemoglobin | 35 | $156 | $3 |
| Urinalysis, manual test | 25 | $86 | $3 |
2016: 27 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 166 | $314,548 | $227 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 105 | $37,372 | $190 |
| Injection, denosumab, 1 mg | 38 | $28,060 | None |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 37 | $25,590 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 179 | $23,354 | $58 |
| Short return visit (20+ min) | 169 | $19,718 | $52 |
| Home dialysis services per month (20 years or older) | 15 | $18,069 | $181 |
| Return visit (30+ min) | 88 | $17,667 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $14,582 | $160 |
| Hemodialysis procedure with physician evaluation | 73 | $5,860 | $59 |
| Short return visit (20+ min) | 71 | $5,102 | $36 |
| Injection of drug or substance under skin or into muscle | 79 | $4,850 | $21 |
| Dialysis procedure including 1 evaluation | 16 | $2,954 | $70 |
| Return visit (30+ min) | 33 | $2,509 | $56 |
| Dialysis services, per day, less than full month service (20 years or older) | 21 | $1,903 | $6 |
| Hospital discharge day management, 30 minutes or less | 28 | $1,831 | $59 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $1,661 | $151 |
| Complete ultrasound scan behind abdominal cavity | 16 | $1,629 | $90 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | $1,579 | $58 |
| New patient visit (15+ min) | 31 | $1,528 | $49 |
| Kidney function blood test panel | 96 | $1,527 | $12 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 41 | $1,404 | $32 |
| Short return visit | 39 | $1,190 | $30 |
| Insertion of needle into vein for collection of blood sample | 107 | $447 | $3 |
| Hemoglobin a1c level | 13 | $233 | $13 |
| Blood count, hemoglobin | 38 | $212 | $3 |
| Manual urinalysis test with examination using microscope, non-automated | 15 | $59 | $4 |
2015: 28 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 205 | $335,987 | $227 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 137 | $51,865 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 200 | $24,523 | $58 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 46 | $24,113 | None |
| Short return visit (20+ min) | 169 | $21,851 | $54 |
| Injection, denosumab, 1 mg | 30 | $21,064 | None |
| Return visit (30+ min) | 93 | $18,023 | $79 |
| Home dialysis services per month (20 years or older) | 13 | $15,807 | $178 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $14,324 | $163 |
| Hemodialysis procedure with physician evaluation | 68 | $5,330 | $57 |
| Injection of drug or substance under skin or into muscle | 80 | $4,862 | $21 |
| Short return visit (20+ min) | 58 | $4,014 | $36 |
| Dialysis services, per day, less than full month service (20 years or older) | 29 | $2,740 | $6 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $1,941 | $139 |
| Complete ultrasound scan behind abdominal cavity | 19 | $1,761 | $93 |
| New patient visit (15+ min) | 25 | $1,480 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 15 | $1,354 | $59 |
| Kidney function blood test panel | 82 | $1,283 | $11 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,272 | $58 |
| Short return visit | 31 | $1,032 | $33 |
| Return visit (30+ min) | 15 | $996 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $957 | $31 |
| New patient visit (30+ min) | 11 | $484 | $44 |
| Insertion of needle into vein for collection of blood sample | 99 | $462 | $3 |
| Administration of influenza virus vaccine | 17 | $425 | $25 |
| Blood count, hemoglobin | 40 | $247 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 17 | $218 | $13 |
| Manual urinalysis test with examination using microscope, non-automated | 20 | $84 | $4 |
2014: 27 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 198 | $319,864 | $225 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 104 | $36,541 | $187 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 44 | $27,024 | None |
| Short return visit (20+ min) | 195 | $23,868 | $53 |
| Return visit (30+ min) | 88 | $16,572 | $80 |
| Home dialysis services per month (20 years or older) | 15 | $16,106 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 157 | $15,724 | $57 |
| Injection, denosumab, 1 mg | 21 | $14,797 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $10,466 | $159 |
| Injection of drug or substance under skin or into muscle | 68 | $5,157 | $20 |
| Short return visit (20+ min) | 45 | $4,439 | $40 |
| Dialysis services, per day, less than full month service (20 years or older) | 30 | $3,623 | $6 |
| Hemodialysis procedure with physician evaluation | 41 | $3,555 | $55 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 12 | $3,432 | $1 |
| Complete ultrasound scan behind abdominal cavity | 30 | $3,075 | $102 |
| New patient visit (15+ min) | 40 | $1,902 | $48 |
| Kidney function blood test panel | 89 | $1,481 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 36 | $1,216 | $30 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | $1,084 | $49 |
| Hospital discharge day management, 30 minutes or less | 18 | $951 | $53 |
| Short return visit | 25 | $742 | $29 |
| Injection of drug or substance into vein | 13 | $565 | $40 |
| Insertion of needle into vein for collection of blood sample | 111 | $538 | $3 |
| Administration of influenza virus vaccine | 19 | $496 | $26 |
| Blood count, hemoglobin | 47 | $301 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 19 | $263 | $14 |
| Manual urinalysis test with examination using microscope, non-automated | 21 | $89 | $4 |
2013: 25 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 203 | $288,562 | $223 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 105 | $36,450 | $190 |
| Short return visit (20+ min) | 194 | $20,978 | $53 |
| Return visit (30+ min) | 109 | $19,671 | $78 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 62 | $17,522 | None |
| Home dialysis services per month (20 years or older) | 17 | $16,636 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 160 | $15,921 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $12,808 | $156 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 28 | $10,212 | $1 |
| Hemodialysis procedure with physician evaluation | 60 | $4,764 | $57 |
| Injection of drug or substance under skin or into muscle | 68 | $3,811 | $21 |
| Short return visit (20+ min) | 42 | $3,430 | $39 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 34 | $3,301 | $63 |
| Dialysis services, per day, less than full month service (20 years or older) | 30 | $2,837 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 70 | $2,537 | $29 |
| Complete ultrasound scan behind abdominal cavity | 22 | $2,486 | $113 |
| New patient visit (15+ min) | 39 | $2,301 | $59 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,663 | $57 |
| Kidney function blood test panel | 81 | $1,392 | $12 |
| Administration of influenza virus vaccine | 18 | $514 | $27 |
| Short return visit | 14 | $504 | $36 |
| Insertion of needle into vein for collection of blood sample | 105 | $477 | $3 |
| Blood count, hemoglobin | 48 | $250 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 11 | $134 | $12 |
| Manual urinalysis test with examination using microscope, non-automated | 12 | $51 | $4 |
Medicaid work
$181,722 in 2024
Medicaid paid $181,722 for 1,688 billed services this clinician did in 2024, up to 75 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 563 | $97,388 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 147 | $35,723 |
| Short return visit (20+ min) | 326 | $16,400 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 90 | $12,559 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 281 | $11,175 |
| Short return visit | 252 | $7,372 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 14 | $778 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 15 | $327 |
| 2024 | 1,688 | 8 | 75 | $181,722 |
| 2023 | 2,258 | 10 | 103 | $244,268 |
| 2022 | 1,967 | 6 | 48 | $180,235 |
| 2021 | 2,053 | 10 | 42 | $151,188 |
| 2020 | 2,045 | 10 | 94 | $139,742 |
| 2019 | 2,368 | 9 | 100 | $177,517 |
| 2018 | 2,312 | 7 | 131 | $206,813 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 747 | $136,297 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 196 | $46,847 |
| Short return visit (20+ min) | 545 | $25,325 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 411 | $18,310 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 56 | $7,021 |
| Short return visit | 200 | $4,921 |
| Return visit (30+ min) | 56 | $4,195 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 16 | $728 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 17 | $623 |
| Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 14 | $0 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 512 | $95,433 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 145 | $30,680 |
| Short return visit (20+ min) | 504 | $24,350 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 548 | $17,842 |
| Return visit (30+ min) | 142 | $9,176 |
| Short return visit | 116 | $2,755 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 439 | $71,639 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 187 | $34,438 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 597 | $20,539 |
| Short return visit (20+ min) | 404 | $16,100 |
| Short return visit | 287 | $7,367 |
| Return visit (30+ min) | 26 | $823 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 12 | $186 |
| OFF/OP EST MAY X REQ PHY/QHP | 12 | $95 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $0 |
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests | 77 | $0 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 620 | $77,060 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 144 | $22,119 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 520 | $18,193 |
| Short return visit (20+ min) | 388 | $12,256 |
| Short return visit | 242 | $4,336 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 25 | $2,850 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 26 | $1,443 |
| Return visit (30+ min) | 26 | $824 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 32 | $607 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 22 | $54 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 847 | $117,625 |
| Short return visit (20+ min) | 768 | $24,394 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 430 | $13,792 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 104 | $12,076 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 31 | $3,269 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 51 | $2,437 |
| Short return visit | 92 | $1,735 |
| Return visit (30+ min) | 33 | $1,414 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $776 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 1,174 | $161,964 |
| Short return visit (20+ min) | 594 | $20,354 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 436 | $17,346 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 51 | $4,224 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 14 | $1,683 |
| Return visit (30+ min) | 27 | $934 |
| Short return visit | 16 | $309 |
Drugs they prescribed that Part D paid
$1,259,687
Pharmacies billed $1,259,687 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (30 of 2,668) in 2024. A higher opioid share than 9 in 10 peers; the typical nephrology clinician is at 0%.
1,876 generic and fewer than 11 brand-name prescriptions · $1,259,687 in drug cost · 112 antibiotic prescriptions to 58 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tarpeyo | 15 | $248,027 | $16,535 |
| Filspari | 21 | $236,052 | $11,241 |
| Jardiance | 165 | $142,814 | $866 |
| Velphoro | 38 | $98,968 | $2,604 |
| Farxiga | 116 | $96,866 | $835 |
See all 60 drugs
| Tarpeyo | 15 | $248,027 | $16,535 |
| Filspari | 21 | $236,052 | $11,241 |
| Jardiance | 165 | $142,814 | $866 |
| Velphoro | 38 | $98,968 | $2,604 |
| Farxiga | 116 | $96,866 | $835 |
| Kerendia | 117 | $82,519 | $705 |
| Veltassa | 46 | $52,142 | $1,134 |
| Rybelsus | 27 | $43,198 | $1,600 |
| Ozempic | 38 | $39,336 | $1,035 |
| Cinacalcet | 58 | $28,935 | $499 |
| Mounjaro | 28 | $27,504 | $982 |
| Linzess | 32 | $22,274 | $696 |
| Trulicity | 24 | $21,032 | $876 |
| Sevelamer Carbonate | 39 | $11,704 | $300 |
| Januvia | 11 | $8,279 | $753 |
| Dapagliflozin | 15 | $6,517 | $434 |
| Calcium Acetate | 43 | $4,632 | $108 |
| Clonidine | 26 | $2,968 | $114 |
| Colchicine | 15 | $2,220 | $148 |
| Potassium Chloride | 17 | $2,176 | $128 |
| Febuxostat | 17 | $1,826 | $107 |
| Metoclopramide | 29 | $1,496 | $52 |
| Bumetanide | 27 | $1,473 | $55 |
| Tamsulosin | 52 | $1,165 | $22 |
| Atorvastatin | 63 | $941 | $15 |
| Losartan | 115 | $938 | $8 |
| Finasteride | 51 | $884 | $17 |
| Gentamicin Sulfate | 24 | $869 | $36 |
| Amlodipine Besylate | 136 | $848 | $6 |
| Metolazone | 26 | $846 | $33 |
| Pantoprazole | 73 | $636 | $9 |
| Doxazosin Mesylate | 27 | $622 | $23 |
| Furosemide | 102 | $614 | $6 |
| Hydralazine | 49 | $573 | $12 |
| Zolpidem | 25 | $445 | $18 |
| Metoprolol | 28 | $415 | $15 |
| Prednisone | 31 | $394 | $13 |
| Carvedilol | 41 | $385 | $9 |
| Levothyroxine | 49 | $385 | $8 |
| Allopurinol | 37 | $373 | $10 |
| Lactulose | 18 | $352 | $20 |
| Clonidine | 16 | $350 | $22 |
| Paroxetine | 17 | $322 | $19 |
| Hydrocodone-Acetaminophen | 25 | $299 | $12 |
| Sucralfate | 13 | $291 | $22 |
| Terazosin | 25 | $287 | $11 |
| Olmesartan Medoxomil | 11 | $250 | $23 |
| Gabapentin | 30 | $241 | $8 |
| Lisinopril | 44 | $225 | $5 |
| Rosuvastatin | 16 | $154 | $10 |
| Omeprazole | 20 | $133 | $7 |
| Hydroxyzine | 16 | $116 | $7 |
| Cephalexin | 32 | $110 | $3 |
| Benazepril | 14 | $100 | $7 |
| Metronidazole | 16 | $87 | $5 |
| Duloxetine | 12 | $63 | $5 |
| Spironolactone | 24 | $53 | $2 |
| Azithromycin | 11 | $49 | $4 |
| Ciprofloxacin | 13 | $46 | $4 |
| Sertraline | 12 | $38 | $3 |
Year by year
| 2024 | 2,668 | 327 | 1% (30) | None | $1,259,687 |
| 2023 | 2,475 | 314 | 1% (26) | None | $801,780 |
| 2022 | 2,323 | 303 | 1% (30) | 21% | $612,624 |
| 2021 | 2,399 | 298 | 2% (40) | 18% | $478,166 |
| 2020 | 2,556 | 294 | 2% (55) | 15% | $377,009 |
| 2019 | 2,889 | 311 | 2% (58) | None | $450,982 |
| 2018 | 3,890 | 355 | 2% (81) | 17% | $692,317 |
| 2017 | 5,052 | 369 | 2% (120) | 22% | $916,503 |
| 2016 | 6,258 | 373 | 3% (166) | 26% | $1,134,694 |
| 2015 | 6,137 | 373 | 3% (158) | 28% | $1,077,379 |
| 2014 | 6,478 | 371 | 3% (163) | 27% | $972,666 |
| 2013 | 5,896 | 360 | 3% (191) | 30% | $822,131 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 59 drugs
| Jardiance | 214 | $192,678 | $900 |
| Velphoro | 32 | $74,196 | $2,319 |
| Farxiga | 94 | $71,523 | $761 |
| Veltassa | 23 | $50,971 | $2,216 |
| Trulicity | 40 | $44,207 | $1,105 |
| Rybelsus | 24 | $37,627 | $1,568 |
| Sevelamer Carbonate | 47 | $31,321 | $666 |
| Kerendia | 38 | $29,923 | $787 |
| Cinacalcet | 16 | $29,707 | $1,857 |
| Ozempic | 22 | $23,298 | $1,059 |
| Rayaldee | 11 | $14,163 | $1,288 |
| Lokelma | 14 | $11,669 | $833 |
| Linzess | 12 | $10,804 | $900 |
| Febuxostat | 27 | $5,563 | $206 |
| Bumetanide | 38 | $3,737 | $98 |
| Clonidine | 12 | $3,128 | $261 |
| Metolazone | 26 | $3,008 | $116 |
| Lidocaine | 12 | $2,571 | $214 |
| Calcium Acetate | 48 | $2,491 | $52 |
| Colchicine | 21 | $2,197 | $105 |
| Amlodipine Besylate | 172 | $2,084 | $12 |
| Losartan | 82 | $2,069 | $25 |
| Levothyroxine | 82 | $2,059 | $25 |
| Atorvastatin | 64 | $2,032 | $32 |
| Tamsulosin | 38 | $1,456 | $38 |
| Finasteride | 38 | $1,240 | $33 |
| Furosemide | 83 | $1,155 | $14 |
| Allopurinol | 51 | $1,017 | $20 |
| Carvedilol | 53 | $996 | $19 |
| Hydralazine | 50 | $976 | $20 |
| Tacrolimus | 12 | $954 | $80 |
| Ventolin Hfa | 15 | $930 | $62 |
| Metoprolol | 56 | $908 | $16 |
| Doxazosin Mesylate | 26 | $896 | $34 |
| Chlorthalidone | 19 | $865 | $46 |
| Pantoprazole | 45 | $743 | $17 |
| Nifedipine Er | 13 | $677 | $52 |
| Mycophenolate Mofetil | 25 | $676 | $27 |
| Potassium Chloride | 24 | $612 | $26 |
| Clonidine | 29 | $563 | $19 |
| Terazosin | 32 | $530 | $17 |
| Minoxidil | 15 | $493 | $33 |
| Gentamicin Sulfate | 12 | $459 | $38 |
| Hydrocodone-Acetaminophen | 20 | $438 | $22 |
| Zolpidem | 19 | $414 | $22 |
| Famotidine | 25 | $413 | $17 |
| Prednisone | 31 | $405 | $13 |
| Paroxetine | 21 | $385 | $18 |
| Duloxetine | 14 | $340 | $24 |
| Lisinopril | 25 | $340 | $14 |
| Benazepril | 21 | $312 | $15 |
| Lactulose | 11 | $261 | $24 |
| Lorazepam | 26 | $226 | $9 |
| Ondansetron | 13 | $221 | $17 |
| Metoclopramide | 28 | $188 | $7 |
| Cephalexin | 17 | $158 | $9 |
| Azithromycin | 16 | $103 | $6 |
| Levofloxacin | 14 | $96 | $7 |
| Hydrochlorothiazide | 21 | $75 | $4 |
2022: 66 drugs
| Jardiance | 121 | $120,888 | $999 |
| Velphoro | 28 | $77,054 | $2,752 |
| Rybelsus | 31 | $39,800 | $1,284 |
| Trulicity | 35 | $37,099 | $1,060 |
| Lokelma | 35 | $36,771 | $1,051 |
| Sevelamer Carbonate | 32 | $35,421 | $1,107 |
| Renvela | 13 | $34,894 | $2,684 |
| Veltassa | 19 | $34,669 | $1,825 |
| Ozempic | 26 | $26,737 | $1,028 |
| Rayaldee | 19 | $23,460 | $1,235 |
| Farxiga | 18 | $16,763 | $931 |
| Auryxia | 15 | $14,461 | $964 |
| Clonidine | 13 | $4,782 | $368 |
| Metolazone | 52 | $4,582 | $88 |
| Colchicine | 13 | $4,537 | $349 |
| Bumetanide | 35 | $2,898 | $83 |
| Calcium Acetate | 39 | $2,357 | $60 |
| Chlorthalidone | 47 | $1,828 | $39 |
| Mycophenolate Mofetil | 29 | $1,543 | $53 |
| Febuxostat | 13 | $1,510 | $116 |
| Tacrolimus | 11 | $1,349 | $123 |
| Losartan | 83 | $1,191 | $14 |
| Carvedilol | 83 | $990 | $12 |
| Amlodipine Besylate | 128 | $946 | $7 |
| Levothyroxine | 44 | $904 | $21 |
| Nifedipine Er | 11 | $895 | $81 |
| Gentamicin Sulfate | 16 | $851 | $53 |
| Lactulose | 11 | $827 | $75 |
| Famotidine | 37 | $764 | $21 |
| Nystatin | 18 | $730 | $41 |
| Tamsulosin | 35 | $721 | $21 |
| Furosemide | 90 | $719 | $8 |
| Allopurinol | 42 | $716 | $17 |
| Nano 2nd Gen Pen Needle | 12 | $716 | $60 |
| Atorvastatin | 58 | $648 | $11 |
| Pantoprazole | 32 | $639 | $20 |
| Doxazosin Mesylate | 30 | $639 | $21 |
| Olmesartan Medoxomil | 11 | $615 | $56 |
| Hydralazine | 32 | $562 | $18 |
| Hydrocodone-Acetaminophen | 23 | $558 | $24 |
| Sucralfate | 14 | $479 | $34 |
| Finasteride | 30 | $467 | $16 |
| Clonidine | 36 | $463 | $13 |
| Gabapentin | 31 | $432 | $14 |
| Terazosin | 27 | $389 | $14 |
| Paroxetine | 12 | $358 | $30 |
| Zolpidem | 17 | $355 | $21 |
| Metoprolol | 62 | $355 | $6 |
| Lisinopril | 27 | $316 | $12 |
| Metoclopramide | 41 | $312 | $8 |
| Oxybutynin Chloride | 12 | $302 | $25 |
| Potassium Chloride | 18 | $301 | $17 |
| Minoxidil | 12 | $287 | $24 |
| Benazepril | 17 | $256 | $15 |
| Metformin | 15 | $234 | $16 |
| Prednisone | 16 | $220 | $14 |
| Triamterene-Hydrochlorothiazid | 17 | $195 | $11 |
| Torsemide | 12 | $172 | $14 |
| Sulfamethoxazole-Trimethoprim | 11 | $169 | $15 |
| Cephalexin | 22 | $152 | $7 |
| Lorazepam | 16 | $130 | $8 |
| Amitriptyline | 17 | $129 | $8 |
| Amoxicillin-Clavulanate Potass | 12 | $102 | $9 |
| Fludrocortisone Acetate | 11 | $93 | $8 |
| Hydrochlorothiazide | 22 | $82 | $4 |
| Levofloxacin | 12 | $64 | $5 |
2021: 58 drugs
| Velphoro | 32 | $77,309 | $2,416 |
| Jardiance | 49 | $66,254 | $1,352 |
| Lokelma | 58 | $48,046 | $828 |
| Auryxia | 32 | $39,670 | $1,240 |
| Sevelamer Carbonate | 69 | $37,280 | $540 |
| Veltassa | 30 | $36,078 | $1,203 |
| Trulicity | 21 | $19,421 | $925 |
| Renvela | 16 | $18,200 | $1,138 |
| Febuxostat | 30 | $6,619 | $221 |
| Retacrit | 15 | $6,608 | $441 |
| Tacrolimus | 27 | $4,846 | $179 |
| Colchicine | 16 | $4,482 | $280 |
| Metolazone | 65 | $3,948 | $61 |
| Bumetanide | 42 | $3,465 | $83 |
| Chlorthalidone | 63 | $2,393 | $38 |
| Clonidine | 16 | $2,384 | $149 |
| Calcium Acetate | 41 | $2,132 | $52 |
| Nifedipine Er | 18 | $1,596 | $89 |
| Losartan | 100 | $1,322 | $13 |
| Mycophenolate Mofetil | 26 | $1,143 | $44 |
| Amlodipine Besylate | 136 | $1,139 | $8 |
| Carvedilol | 92 | $1,054 | $11 |
| Furosemide | 134 | $1,038 | $8 |
| Atorvastatin | 57 | $881 | $15 |
| Doxazosin Mesylate | 31 | $811 | $26 |
| Tamsulosin | 49 | $777 | $16 |
| Famotidine | 34 | $734 | $22 |
| Potassium Chloride | 28 | $668 | $24 |
| Allopurinol | 32 | $661 | $21 |
| Hydralazine | 48 | $655 | $14 |
| Hydrocodone-Acetaminophen | 31 | $650 | $21 |
| Terazosin | 36 | $629 | $17 |
| Gentamicin Sulfate | 12 | $590 | $49 |
| Ondansetron Odt | 12 | $562 | $47 |
| Lactulose | 30 | $535 | $18 |
| Levothyroxine | 30 | $503 | $17 |
| Clonidine | 29 | $496 | $17 |
| Minoxidil | 12 | $454 | $38 |
| Benazepril | 31 | $452 | $15 |
| Oxybutynin Chloride | 14 | $418 | $30 |
| Lisinopril | 40 | $393 | $10 |
| Prednisone | 35 | $355 | $10 |
| Finasteride | 21 | $315 | $15 |
| Pantoprazole | 23 | $296 | $13 |
| Ondansetron | 11 | $276 | $25 |
| Metoprolol | 37 | $271 | $7 |
| Ramipril | 15 | $256 | $17 |
| Gabapentin | 21 | $248 | $12 |
| Omeprazole | 16 | $244 | $15 |
| Mupirocin | 19 | $235 | $12 |
| Alfuzosin Hcl Er | 14 | $227 | $16 |
| Sulfamethoxazole-Trimethoprim | 18 | $206 | $11 |
| Cephalexin | 21 | $153 | $7 |
| Lorazepam | 12 | $143 | $12 |
| Metformin | 16 | $135 | $8 |
| Metoclopramide | 20 | $126 | $6 |
| Amoxicillin-Clavulanate Potass | 14 | $123 | $9 |
| Hydrochlorothiazide | 26 | $80 | $3 |
2020: 61 drugs
| Veltassa | 50 | $54,029 | $1,081 |
| Velphoro | 22 | $53,150 | $2,416 |
| Auryxia | 28 | $36,280 | $1,296 |
| Sevelamer Carbonate | 81 | $33,341 | $412 |
| Jardiance | 30 | $32,163 | $1,072 |
| Renvela | 13 | $32,067 | $2,467 |
| Cinacalcet | 22 | $14,407 | $655 |
| Lokelma | 13 | $8,677 | $667 |
| Febuxostat | 27 | $8,664 | $321 |
| Tacrolimus | 28 | $7,387 | $264 |
| Farxiga | 11 | $5,968 | $543 |
| Calcium Acetate | 33 | $5,377 | $163 |
| Steglatro | 13 | $3,953 | $304 |
| Chlorthalidone | 98 | $3,524 | $36 |
| Colchicine | 11 | $2,922 | $266 |
| Metolazone | 34 | $2,592 | $76 |
| Clonidine | 21 | $2,567 | $122 |
| Nifedipine Er | 28 | $2,083 | $74 |
| Bumetanide | 26 | $1,955 | $75 |
| Divalproex Sodium Er | 11 | $1,545 | $140 |
| Doxazosin Mesylate | 52 | $1,355 | $26 |
| Mycophenolate Mofetil | 20 | $1,167 | $58 |
| Losartan | 92 | $1,138 | $12 |
| Furosemide | 171 | $1,124 | $7 |
| Carvedilol | 113 | $900 | $8 |
| Amlodipine Besylate | 156 | $887 | $6 |
| Gentamicin Sulfate | 18 | $839 | $47 |
| Clonidine | 24 | $812 | $34 |
| Tamsulosin | 78 | $770 | $10 |
| Atorvastatin | 61 | $718 | $12 |
| Terazosin | 43 | $712 | $17 |
| Prednisone | 41 | $697 | $17 |
| Allopurinol | 53 | $626 | $12 |
| Hydralazine | 39 | $612 | $16 |
| Gabapentin | 68 | $576 | $8 |
| Hydrocodone-Acetaminophen | 44 | $575 | $13 |
| Pantoprazole | 50 | $542 | $11 |
| Olmesartan Medoxomil | 15 | $508 | $34 |
| Omeprazole | 30 | $450 | $15 |
| Lactulose | 19 | $436 | $23 |
| Levothyroxine | 31 | $402 | $13 |
| Lisinopril | 46 | $389 | $8 |
| Minoxidil | 22 | $352 | $16 |
| Finasteride | 25 | $343 | $14 |
| Ramipril | 17 | $282 | $17 |
| Benazepril | 25 | $277 | $11 |
| Metoprolol | 39 | $274 | $7 |
| Famotidine | 19 | $258 | $14 |
| Potassium Chloride | 12 | $253 | $21 |
| Paroxetine | 17 | $224 | $13 |
| Cephalexin | 27 | $220 | $8 |
| Mupirocin | 20 | $175 | $9 |
| Sulfamethoxazole-Trimethoprim | 13 | $173 | $13 |
| Spironolactone | 22 | $164 | $7 |
| Alfuzosin Hcl Er | 14 | $140 | $10 |
| Metformin | 20 | $87 | $4 |
| Zolpidem | 17 | $86 | $5 |
| Temazepam | 11 | $75 | $7 |
| Hydrochlorothiazide | 19 | $59 | $3 |
| Ropinirole | 11 | $59 | $5 |
| Metoclopramide | 11 | $55 | $5 |
2019: 59 drugs
| Velphoro | 38 | $68,907 | $1,813 |
| Renvela | 40 | $64,103 | $1,603 |
| Veltassa | 59 | $56,501 | $958 |
| Sevelamer Carbonate | 86 | $50,011 | $582 |
| Auryxia | 39 | $41,477 | $1,064 |
| Jardiance | 14 | $17,206 | $1,229 |
| Uloric | 34 | $15,936 | $469 |
| Lanthanum Carbonate | 14 | $13,593 | $971 |
| Rayaldee | 11 | $12,299 | $1,118 |
| Febuxostat | 21 | $8,946 | $426 |
| Farxiga | 14 | $7,021 | $501 |
| Chlorthalidone | 97 | $3,260 | $34 |
| Calcium Acetate | 63 | $3,235 | $51 |
| Metolazone | 26 | $3,107 | $119 |
| Nifedipine Er | 22 | $1,948 | $89 |
| Doxazosin Mesylate | 82 | $1,917 | $23 |
| Bumetanide | 25 | $1,783 | $71 |
| Gentamicin Sulfate | 25 | $1,500 | $60 |
| Amlodipine Besylate | 175 | $1,259 | $7 |
| Tamsulosin | 88 | $1,187 | $13 |
| Losartan | 133 | $1,162 | $9 |
| Hydralazine | 60 | $1,076 | $18 |
| Atorvastatin | 80 | $1,072 | $13 |
| Terazosin | 58 | $1,043 | $18 |
| Hydrocodone-Acetaminophen | 44 | $993 | $23 |
| Carvedilol | 147 | $972 | $7 |
| Omeprazole | 44 | $846 | $19 |
| Furosemide | 142 | $823 | $6 |
| Allopurinol | 60 | $570 | $9 |
| Clonidine | 40 | $567 | $14 |
| Famotidine | 39 | $432 | $11 |
| Levothyroxine | 26 | $398 | $15 |
| Irbesartan | 21 | $389 | $19 |
| Metoprolol | 60 | $372 | $6 |
| Prednisone | 48 | $319 | $7 |
| Pantoprazole | 16 | $223 | $14 |
| Paroxetine | 27 | $223 | $8 |
| Gabapentin | 46 | $216 | $5 |
| Zolpidem | 18 | $214 | $12 |
| Lisinopril | 35 | $210 | $6 |
| Minoxidil | 18 | $198 | $11 |
| Trazodone | 13 | $167 | $13 |
| Sulfamethoxazole-Trimethoprim | 20 | $161 | $8 |
| Cephalexin | 26 | $155 | $6 |
| Ramipril | 11 | $146 | $13 |
| Lactulose | 20 | $145 | $7 |
| Ropinirole | 16 | $142 | $9 |
| Lorazepam | 11 | $138 | $13 |
| Mupirocin | 27 | $136 | $5 |
| Spironolactone | 20 | $106 | $5 |
| Hydrochlorothiazide | 33 | $98 | $3 |
| Simvastatin | 22 | $97 | $4 |
| Azithromycin | 15 | $75 | $5 |
| Metformin | 12 | $75 | $6 |
| Tramadol | 11 | $71 | $6 |
| Atenolol | 15 | $65 | $4 |
| Glipizide | 13 | $62 | $5 |
| Metoclopramide | 11 | $61 | $6 |
| Benazepril | 11 | $58 | $5 |
2018: 75 drugs
| Renvela | 118 | $227,750 | $1,930 |
| Veltassa | 86 | $72,315 | $841 |
| Auryxia | 53 | $54,605 | $1,030 |
| Sevelamer Carbonate | 52 | $36,701 | $706 |
| Sensipar | 30 | $31,850 | $1,062 |
| Uloric | 50 | $22,357 | $447 |
| Jardiance | 11 | $11,793 | $1,072 |
| Novolog Flexpen | 16 | $10,440 | $653 |
| Amitiza | 13 | $4,916 | $378 |
| Colchicine | 16 | $4,872 | $304 |
| Calcium Acetate | 70 | $4,607 | $66 |
| Metolazone | 52 | $3,970 | $76 |
| Chlorthalidone | 109 | $3,851 | $35 |
| Doxazosin Mesylate | 135 | $3,310 | $25 |
| Clonidine | 23 | $2,773 | $121 |
| Bumetanide | 57 | $2,667 | $47 |
| Mycophenolate Mofetil | 24 | $2,630 | $110 |
| Hydrocodone-Acetaminophen | 67 | $1,333 | $20 |
| Tamsulosin | 83 | $1,284 | $15 |
| Losartan | 169 | $1,236 | $7 |
| Ultra-Fine Short Pen Needle | 21 | $1,230 | $59 |
| Atorvastatin | 98 | $1,110 | $11 |
| Midodrine | 17 | $1,080 | $64 |
| Nifedipine Er | 27 | $1,064 | $39 |
| Gentamicin Sulfate | 18 | $1,055 | $59 |
| Hydralazine | 65 | $1,047 | $16 |
| Valsartan | 37 | $1,029 | $28 |
| Amlodipine Besylate | 198 | $1,005 | $5 |
| Carvedilol | 178 | $850 | $5 |
| Gabapentin | 97 | $725 | $7 |
| Ventolin Hfa | 13 | $720 | $55 |
| Metoprolol | 120 | $621 | $5 |
| Zolpidem | 61 | $567 | $9 |
| Furosemide | 122 | $517 | $4 |
| Allopurinol | 44 | $502 | $11 |
| Famotidine | 54 | $499 | $9 |
| Omeprazole | 56 | $432 | $8 |
| Levothyroxine | 30 | $426 | $14 |
| Prednisone | 72 | $408 | $6 |
| Duloxetine | 21 | $408 | $19 |
| Terazosin | 60 | $393 | $7 |
| Nystatin | 11 | $381 | $35 |
| Metoprolol | 15 | $376 | $25 |
| Minoxidil | 29 | $336 | $12 |
| Clonidine | 47 | $332 | $7 |
| Isosorbide Mononitrate Er | 19 | $303 | $16 |
| Lactulose | 30 | $280 | $9 |
| Clopidogrel | 18 | $270 | $15 |
| Hydrochlorothiazide | 64 | $254 | $4 |
| Cartia Xt | 12 | $248 | $21 |
| Cephalexin | 38 | $224 | $6 |
| Benazepril | 21 | $220 | $10 |
| Olmesartan Medoxomil | 11 | $205 | $19 |
| Promethazine | 26 | $201 | $8 |
| Lisinopril | 51 | $173 | $3 |
| Alprazolam | 23 | $164 | $7 |
| Levofloxacin | 19 | $163 | $9 |
| Pantoprazole | 20 | $152 | $8 |
| Paroxetine | 25 | $145 | $6 |
| Azithromycin | 21 | $142 | $7 |
| Glimepiride | 14 | $140 | $10 |
| Calcitriol | 15 | $125 | $8 |
| Spironolactone | 26 | $118 | $5 |
| Sulfamethoxazole-Trimethoprim | 32 | $113 | $4 |
| Simvastatin | 23 | $113 | $5 |
| Ramipril | 19 | $110 | $6 |
| Pravastatin | 14 | $104 | $7 |
| Ciprofloxacin | 11 | $91 | $8 |
| Trazodone | 12 | $81 | $7 |
| Ropinirole | 12 | $73 | $6 |
| Generlac | 12 | $65 | $5 |
| Glipizide | 24 | $65 | $3 |
| Lorazepam | 13 | $36 | $3 |
| Atenolol | 17 | $27 | $2 |
| Metformin | 15 | $25 | $2 |
2017: 86 drugs
| Renvela | 264 | $427,958 | $1,621 |
| Sensipar | 102 | $128,933 | $1,264 |
| Veltassa | 89 | $58,385 | $656 |
| Auryxia | 20 | $20,049 | $1,002 |
| Fosrenol | 17 | $18,063 | $1,063 |
| Novolog Flexpen | 28 | $15,042 | $537 |
| Uloric | 25 | $14,547 | $582 |
| Novolog | 14 | $11,510 | $822 |
| Colchicine | 25 | $8,655 | $346 |
| Lantus Solostar | 16 | $6,065 | $379 |
| Amitiza | 20 | $5,872 | $294 |
| Linzess | 15 | $5,409 | $361 |
| Calcium Acetate | 63 | $4,685 | $74 |
| Clonidine | 30 | $4,310 | $144 |
| Breo Ellipta | 13 | $4,183 | $322 |
| Metolazone | 53 | $3,660 | $69 |
| Levemir | 13 | $3,478 | $268 |
| Olmesartan Medoxomil | 29 | $3,336 | $115 |
| Mycophenolate Mofetil | 24 | $2,392 | $100 |
| Doxazosin Mesylate | 88 | $2,330 | $26 |
| Ventolin Hfa | 39 | $2,087 | $54 |
| Midodrine | 23 | $1,994 | $87 |
| Hydralazine | 131 | $1,913 | $15 |
| Atorvastatin | 175 | $1,838 | $11 |
| Chlorthalidone | 59 | $1,815 | $31 |
| Amlodipine Besylate | 402 | $1,667 | $4 |
| Ultra-Fine Short Pen Needle | 29 | $1,647 | $57 |
| Leflunomide | 12 | $1,626 | $136 |
| Bumetanide | 26 | $1,287 | $50 |
| Hydrocodone-Acetaminophen | 81 | $1,252 | $15 |
| Gabapentin | 186 | $1,229 | $7 |
| Omeprazole | 147 | $1,151 | $8 |
| Gentamicin Sulfate | 19 | $1,122 | $59 |
| Valsartan | 51 | $1,071 | $21 |
| Metoprolol | 195 | $887 | $5 |
| Zolpidem | 71 | $857 | $12 |
| Losartan | 125 | $832 | $7 |
| Phenytoin Sodium Extended | 11 | $777 | $71 |
| Tamsulosin | 59 | $758 | $13 |
| Furosemide | 197 | $750 | $4 |
| Levothyroxine | 54 | $700 | $13 |
| Metoprolol | 17 | $667 | $39 |
| Nifedipine Er | 31 | $655 | $21 |
| Duloxetine | 27 | $647 | $24 |
| Carvedilol | 144 | $626 | $4 |
| Allopurinol | 49 | $612 | $12 |
| Prednisone | 88 | $610 | $7 |
| Oxycodone-Acetaminophen | 19 | $489 | $26 |
| Terazosin | 74 | $461 | $6 |
| Calcitriol | 37 | $446 | $12 |
| Clopidogrel | 48 | $446 | $9 |
| Potassium Chloride | 29 | $392 | $14 |
| Isosorbide Mononitrate Er | 25 | $366 | $15 |
| Doxycycline Hyclate | 20 | $365 | $18 |
| Pantoprazole | 52 | $328 | $6 |
| Lactulose | 42 | $314 | $7 |
| Clonidine | 42 | $313 | $7 |
| Lisinopril | 73 | $266 | $4 |
| Promethazine | 26 | $255 | $10 |
| Simvastatin | 60 | $241 | $4 |
| Benazepril | 45 | $239 | $5 |
| Minoxidil | 18 | $206 | $11 |
| Amitriptyline | 19 | $200 | $11 |
| Cephalexin | 28 | $196 | $7 |
| Hydrochlorothiazide | 52 | $176 | $3 |
| Glimepiride | 13 | $168 | $13 |
| Metoclopramide | 19 | $167 | $9 |
| Famotidine | 22 | $166 | $8 |
| Ramipril | 23 | $154 | $7 |
| Generlac | 24 | $143 | $6 |
| Sulfamethoxazole-Trimethoprim | 35 | $140 | $4 |
| Tramadol | 18 | $135 | $7 |
| Azithromycin | 19 | $133 | $7 |
| Spironolactone | 25 | $124 | $5 |
| Pramipexole Dihydrochloride | 19 | $120 | $6 |
| Paroxetine | 14 | $104 | $7 |
| Levofloxacin | 16 | $102 | $6 |
| Metformin | 32 | $99 | $3 |
| Ciprofloxacin | 13 | $82 | $6 |
| Glipizide | 25 | $71 | $3 |
| Ropinirole | 11 | $66 | $6 |
| Alprazolam | 12 | $62 | $5 |
| Ranitidine | 18 | $61 | $3 |
| Citalopram Hbr | 14 | $59 | $4 |
| Sertraline | 19 | $54 | $3 |
| Fluoxetine | 22 | $30 | $1 |
2016: 103 drugs
| Renvela | 451 | $639,962 | $1,419 |
| Sensipar | 110 | $120,388 | $1,094 |
| Veltassa | 72 | $45,098 | $626 |
| Renagel | 21 | $37,326 | $1,777 |
| Fosrenol | 29 | $32,822 | $1,132 |
| Novolog Flexpen | 31 | $15,034 | $485 |
| Calcium Acetate | 155 | $13,517 | $87 |
| Uloric | 28 | $12,938 | $462 |
| Humalog | 24 | $11,548 | $481 |
| Lantus Solostar | 23 | $10,218 | $444 |
| Lantus | 32 | $9,056 | $283 |
| Humalog Kwikpen U-100 | 15 | $8,055 | $537 |
| Advair Diskus | 22 | $7,511 | $341 |
| Asacol Hd | 11 | $7,262 | $660 |
| Clonidine | 46 | $6,934 | $151 |
| Atrovent Hfa | 21 | $6,418 | $306 |
| Vesicare | 20 | $6,032 | $302 |
| Metolazone | 73 | $5,100 | $70 |
| Invanz | 11 | $4,410 | $401 |
| Spiriva | 12 | $4,030 | $336 |
| Xarelto | 11 | $3,886 | $353 |
| Crestor | 11 | $2,775 | $252 |
| Hydrocodone-Acetaminophen | 129 | $2,724 | $21 |
| Novolin 70-30 | 15 | $2,548 | $170 |
| Colchicine | 12 | $2,027 | $169 |
| Amlodipine Besylate | 554 | $2,001 | $4 |
| Atorvastatin | 158 | $1,922 | $12 |
| Ventolin Hfa | 35 | $1,836 | $52 |
| Omeprazole | 271 | $1,818 | $7 |
| Bd Ultra-Fine Pen Needle | 33 | $1,764 | $53 |
| Hydralazine | 133 | $1,748 | $13 |
| Bumetanide | 34 | $1,473 | $43 |
| Doxazosin Mesylate | 58 | $1,369 | $24 |
| Isosorbide Dinitrate | 15 | $1,273 | $85 |
| Losartan | 211 | $1,257 | $6 |
| Mycophenolate Mofetil | 22 | $1,228 | $56 |
| Duloxetine | 40 | $1,139 | $28 |
| Lidocaine-Prilocaine | 39 | $1,118 | $29 |
| Gabapentin | 200 | $1,070 | $5 |
| Levothyroxine | 58 | $1,005 | $17 |
| Tamsulosin | 44 | $991 | $23 |
| Carvedilol | 193 | $924 | $5 |
| Metoprolol | 240 | $881 | $4 |
| Oxycodone-Acetaminophen | 16 | $739 | $46 |
| Prednisone | 99 | $719 | $7 |
| Furosemide | 245 | $701 | $3 |
| Phenytoin Sodium Extended | 11 | $688 | $63 |
| Diphenoxylate-Atropine | 21 | $643 | $31 |
| Allopurinol | 47 | $618 | $13 |
| Nifedipine Er | 20 | $608 | $30 |
| Repaglinide | 17 | $604 | $36 |
| Valsartan | 20 | $598 | $30 |
| Chlorthalidone | 20 | $524 | $26 |
| Benazepril | 116 | $500 | $4 |
| Metoprolol | 26 | $494 | $19 |
| Minoxidil | 34 | $486 | $14 |
| Insulin | 16 | $419 | $26 |
| Clonidine | 58 | $412 | $7 |
| Lisinopril | 97 | $396 | $4 |
| Hydrochlorothiazide | 94 | $389 | $4 |
| Ramipril | 41 | $384 | $9 |
| Megestrol Acetate | 14 | $383 | $27 |
| Clopidogrel | 38 | $374 | $10 |
| Famotidine | 28 | $367 | $13 |
| Finasteride | 13 | $347 | $27 |
| Levofloxacin | 35 | $346 | $10 |
| Simvastatin | 87 | $338 | $4 |
| Enalapril Maleate | 12 | $315 | $26 |
| Lactulose | 37 | $301 | $8 |
| Generlac | 35 | $269 | $8 |
| Valsartan-Hydrochlorothiazide | 16 | $266 | $17 |
| Calcitriol | 14 | $246 | $18 |
| Cephalexin | 39 | $241 | $6 |
| Pravastatin | 18 | $234 | $13 |
| Terazosin | 38 | $214 | $6 |
| Spironolactone | 35 | $211 | $6 |
| Azithromycin | 34 | $203 | $6 |
| Isosorbide Mononitrate Er | 20 | $201 | $10 |
| Alprazolam | 35 | $198 | $6 |
| Metoclopramide | 41 | $184 | $4 |
| Zolpidem | 52 | $175 | $3 |
| Glipizide | 57 | $167 | $3 |
| Potassium Chloride | 12 | $156 | $13 |
| Pantoprazole | 26 | $153 | $6 |
| Ropinirole | 26 | $153 | $6 |
| Sucralfate | 14 | $139 | $10 |
| Fluticasone Propionate | 11 | $135 | $12 |
| Promethazine | 12 | $132 | $11 |
| Trandolapril | 11 | $123 | $11 |
| Metformin | 33 | $87 | $3 |
| Amitriptyline | 11 | $86 | $8 |
| Tramadol | 16 | $85 | $5 |
| Fluoxetine | 30 | $76 | $3 |
| Temazepam | 16 | $59 | $4 |
| Ranitidine | 18 | $59 | $3 |
| Atenolol | 15 | $55 | $4 |
| Trazodone | 13 | $45 | $3 |
| Sulfamethoxazole-Trimethoprim | 17 | $42 | $2 |
| Citalopram Hbr | 18 | $40 | $2 |
| Metformin Hcl Er | 11 | $39 | $4 |
| Sertraline | 13 | $38 | $3 |
| Lorazepam | 15 | $27 | $2 |
| Diazepam | 16 | $25 | $2 |
2015: 102 drugs
| Renvela | 477 | $590,354 | $1,238 |
| Sensipar | 156 | $135,073 | $866 |
| Fosrenol | 42 | $51,706 | $1,231 |
| Renagel | 18 | $32,280 | $1,793 |
| Velphoro | 19 | $22,030 | $1,159 |
| Novolog Flexpen | 30 | $12,829 | $428 |
| Calcium Acetate | 134 | $11,449 | $85 |
| Lantus | 36 | $11,108 | $309 |
| Sevelamer Carbonate | 14 | $10,533 | $752 |
| Lantus Solostar | 25 | $10,272 | $411 |
| Humalog | 24 | $8,448 | $352 |
| Novolog | 30 | $8,384 | $279 |
| Uloric | 20 | $7,738 | $387 |
| Vesicare | 31 | $7,643 | $247 |
| Advair Diskus | 19 | $5,900 | $311 |
| Clonidine | 32 | $5,843 | $183 |
| Metolazone | 66 | $4,822 | $73 |
| Colchicine | 12 | $3,873 | $323 |
| Atrovent Hfa | 13 | $3,493 | $269 |
| Crestor | 16 | $3,416 | $214 |
| Tamsulosin | 69 | $2,493 | $36 |
| Novolin 70-30 | 19 | $2,254 | $119 |
| Omeprazole | 267 | $2,168 | $8 |
| Amlodipine Besylate | 507 | $2,026 | $4 |
| Atorvastatin | 177 | $1,920 | $11 |
| Hydrocodone-Acetaminophen | 104 | $1,736 | $17 |
| Isosorbide Dinitrate | 23 | $1,725 | $75 |
| Duloxetine | 26 | $1,700 | $65 |
| Doxazosin Mesylate | 68 | $1,681 | $25 |
| Bumetanide | 42 | $1,527 | $36 |
| Losartan | 209 | $1,357 | $6 |
| Lidocaine-Prilocaine | 40 | $1,259 | $31 |
| Hydralazine | 111 | $1,236 | $11 |
| Proair Hfa | 24 | $1,221 | $51 |
| Metoprolol | 268 | $1,104 | $4 |
| Gabapentin | 182 | $1,071 | $6 |
| Levothyroxine | 64 | $1,051 | $16 |
| Mycophenolate Mofetil | 14 | $978 | $70 |
| Carvedilol | 181 | $934 | $5 |
| Insulin | 32 | $826 | $26 |
| Furosemide | 226 | $809 | $4 |
| Felodipine Er | 24 | $712 | $30 |
| Bd Ultra-Fine Pen Needle | 13 | $686 | $53 |
| Enalapril Maleate | 20 | $660 | $33 |
| Prednisone | 79 | $639 | $8 |
| Amoxicillin-Clavulanate Potass | 22 | $631 | $29 |
| Lisinopril | 124 | $628 | $5 |
| Valsartan | 15 | $616 | $41 |
| Oxycodone-Acetaminophen | 17 | $609 | $36 |
| Chlorthalidone | 23 | $551 | $24 |
| Benazepril | 135 | $545 | $4 |
| Diphenoxylate-Atropine | 24 | $529 | $22 |
| Metoprolol | 26 | $523 | $20 |
| Minoxidil | 40 | $523 | $13 |
| Insulin | 19 | $485 | $26 |
| Nifedipine Er | 15 | $462 | $31 |
| Pravastatin | 20 | $437 | $22 |
| Levofloxacin | 54 | $430 | $8 |
| Amiodarone | 21 | $416 | $20 |
| Zolpidem | 50 | $401 | $8 |
| Simvastatin | 83 | $400 | $5 |
| Pantoprazole | 45 | $367 | $8 |
| Lactulose | 32 | $365 | $11 |
| Clonidine | 43 | $364 | $8 |
| Hydrochlorothiazide | 86 | $350 | $4 |
| Azithromycin | 49 | $344 | $7 |
| Famotidine | 47 | $317 | $7 |
| Calcitriol | 17 | $284 | $17 |
| Valsartan-Hydrochlorothiazide | 17 | $281 | $17 |
| Alprazolam | 56 | $269 | $5 |
| Meclizine | 18 | $245 | $14 |
| Nitrostat | 12 | $236 | $20 |
| Isosorbide Mononitrate Er | 22 | $234 | $11 |
| Fluoxetine | 32 | $231 | $7 |
| Insulin | 11 | $210 | $19 |
| Finasteride | 16 | $207 | $13 |
| Cephalexin | 30 | $205 | $7 |
| Ramipril | 16 | $195 | $12 |
| Glipizide | 55 | $194 | $4 |
| Cartia Xt | 11 | $191 | $17 |
| Terazosin | 33 | $185 | $6 |
| Allopurinol | 12 | $180 | $15 |
| Fluconazole | 12 | $154 | $13 |
| Clopidogrel | 31 | $149 | $5 |
| Ropinirole | 15 | $149 | $10 |
| Spironolactone | 26 | $147 | $6 |
| Metoclopramide | 29 | $139 | $5 |
| Tramadol | 32 | $130 | $4 |
| Atenolol | 21 | $129 | $6 |
| Cilostazol | 12 | $119 | $10 |
| Generlac | 14 | $115 | $8 |
| Amitriptyline | 16 | $108 | $7 |
| Metformin | 30 | $96 | $3 |
| Promethazine | 12 | $87 | $7 |
| Diazepam | 17 | $81 | $5 |
| Lovastatin | 23 | $74 | $3 |
| Donepezil | 11 | $69 | $6 |
| Ciprofloxacin | 12 | $63 | $5 |
| Trandolapril | 11 | $60 | $5 |
| Ranitidine | 12 | $54 | $5 |
| Citalopram Hbr | 19 | $42 | $2 |
| Trazodone | 11 | $23 | $2 |
2014: 100 drugs
| Renvela | 563 | $484,415 | $860 |
| Sensipar | 215 | $167,672 | $780 |
| Fosrenol | 38 | $44,333 | $1,167 |
| Sevelamer Carbonate | 49 | $35,884 | $732 |
| Renagel | 25 | $30,267 | $1,211 |
| Calcium Acetate | 190 | $19,057 | $100 |
| Lantus | 46 | $13,598 | $296 |
| Clonidine | 45 | $8,527 | $189 |
| Novolog | 26 | $7,925 | $305 |
| Doxercalciferol | 12 | $7,336 | $611 |
| Vesicare | 31 | $6,862 | $221 |
| Zetia | 19 | $6,565 | $346 |
| Uloric | 25 | $5,767 | $231 |
| Humalog | 18 | $5,766 | $320 |
| Novolog Flexpen | 14 | $5,046 | $360 |
| Lantus Solostar | 11 | $4,494 | $409 |
| Colcrys | 15 | $4,084 | $272 |
| Diovan | 22 | $3,825 | $174 |
| Hydralazine | 200 | $3,299 | $16 |
| Atrovent Hfa | 12 | $2,934 | $244 |
| Omeprazole | 259 | $2,923 | $11 |
| Metolazone | 41 | $2,855 | $70 |
| Amlodipine Besylate | 555 | $2,646 | $5 |
| Crestor | 12 | $2,280 | $190 |
| Duloxetine | 17 | $2,208 | $130 |
| Losartan | 242 | $2,070 | $9 |
| Bumetanide | 67 | $1,821 | $27 |
| Hydrocodone-Acetaminophen | 120 | $1,683 | $14 |
| Gabapentin | 214 | $1,645 | $8 |
| Doxazosin Mesylate | 65 | $1,592 | $24 |
| Carvedilol | 194 | $1,440 | $7 |
| Midodrine | 33 | $1,397 | $42 |
| Atorvastatin | 109 | $1,301 | $12 |
| Metoprolol | 239 | $1,283 | $5 |
| Tamsulosin | 66 | $1,260 | $19 |
| Benazepril | 180 | $1,104 | $6 |
| Proair Hfa | 16 | $1,063 | $66 |
| Pioglitazone | 22 | $1,042 | $47 |
| Furosemide | 177 | $993 | $6 |
| Levothyroxine | 69 | $935 | $14 |
| Valsartan-Hydrochlorothiazide | 16 | $858 | $54 |
| Pravastatin | 33 | $857 | $26 |
| Metoprolol | 27 | $801 | $30 |
| Megestrol Acetate | 19 | $747 | $39 |
| Prednisone | 69 | $735 | $11 |
| Fluconazole | 11 | $734 | $67 |
| Felodipine Er | 20 | $726 | $36 |
| Insulin | 31 | $726 | $23 |
| Ropinirole | 23 | $701 | $30 |
| Insulin | 27 | $680 | $25 |
| Verapamil Er | 11 | $619 | $56 |
| Levofloxacin | 46 | $610 | $13 |
| Bd Ultra-Fine Pen Needle | 14 | $571 | $41 |
| Lisinopril | 130 | $560 | $4 |
| Lidocaine-Prilocaine | 23 | $513 | $22 |
| Clonidine | 51 | $513 | $10 |
| Nifedipine Er | 12 | $498 | $41 |
| Fluoxetine | 42 | $490 | $12 |
| Diltiazem 24hr Er | 14 | $457 | $33 |
| Metoclopramide | 50 | $443 | $9 |
| Chlorthalidone | 26 | $442 | $17 |
| Simvastatin | 80 | $438 | $5 |
| Labetalol | 11 | $437 | $40 |
| Minoxidil | 27 | $432 | $16 |
| Calcitriol | 16 | $424 | $27 |
| Isosorbide Mononitrate Er | 34 | $406 | $12 |
| Nifedical Xl | 13 | $398 | $31 |
| Hydrochlorothiazide | 99 | $398 | $4 |
| Lactulose | 30 | $395 | $13 |
| Zolpidem | 49 | $382 | $8 |
| Pantoprazole | 38 | $379 | $10 |
| Enalapril Maleate | 26 | $366 | $14 |
| Clopidogrel | 43 | $312 | $7 |
| Diphenoxylate-Atropine | 26 | $304 | $12 |
| Glipizide | 60 | $297 | $5 |
| Ramipril | 32 | $289 | $9 |
| Cartia Xt | 13 | $279 | $21 |
| Amox Tr-Potassium Clavulanate | 13 | $276 | $21 |
| Terazosin | 42 | $270 | $6 |
| Fluticasone Propionate | 13 | $259 | $20 |
| Pentoxifylline | 12 | $257 | $21 |
| Famotidine | 31 | $254 | $8 |
| Promethazine | 21 | $252 | $12 |
| Sucralfate | 11 | $248 | $23 |
| Tramadol | 32 | $211 | $7 |
| Azithromycin | 25 | $200 | $8 |
| Atenolol | 34 | $181 | $5 |
| Alprazolam | 33 | $170 | $5 |
| Citalopram Hbr | 37 | $157 | $4 |
| Lovastatin | 24 | $156 | $7 |
| Potassium Chloride | 11 | $150 | $14 |
| Sertraline | 18 | $148 | $8 |
| Metformin | 25 | $134 | $5 |
| Allopurinol | 25 | $129 | $5 |
| Amiodarone | 15 | $118 | $8 |
| Cephalexin | 16 | $116 | $7 |
| Amitriptyline | 18 | $115 | $6 |
| Ciprofloxacin | 13 | $110 | $8 |
| Spironolactone | 13 | $91 | $7 |
| Trazodone | 19 | $62 | $3 |
2013: 90 drugs
| Renvela | 475 | $373,670 | $787 |
| Sensipar | 211 | $139,368 | $661 |
| Fosrenol | 55 | $64,363 | $1,170 |
| Renagel | 40 | $36,609 | $915 |
| Calcium Acetate | 170 | $16,348 | $96 |
| Lantus | 69 | $12,887 | $187 |
| Diovan | 44 | $6,945 | $158 |
| Clonidine | 37 | $6,736 | $182 |
| Vesicare | 30 | $6,047 | $202 |
| Novolog Flexpen | 17 | $4,905 | $289 |
| Cymbalta | 19 | $4,610 | $243 |
| Pioglitazone | 42 | $3,794 | $90 |
| Uloric | 19 | $3,784 | $199 |
| Clopidogrel | 66 | $3,695 | $56 |
| Colcrys | 12 | $3,670 | $306 |
| Humalog | 14 | $3,642 | $260 |
| Novolog | 16 | $3,392 | $212 |
| Lantus Solostar | 12 | $3,118 | $260 |
| Levemir Flexpen | 11 | $2,996 | $272 |
| Losartan | 197 | $2,978 | $15 |
| Omeprazole | 187 | $2,841 | $15 |
| Cyclosporine | 11 | $2,785 | $253 |
| Amlodipine Besylate | 424 | $2,641 | $6 |
| Gabapentin | 125 | $2,360 | $19 |
| Midodrine | 42 | $2,345 | $56 |
| Metolazone | 38 | $2,221 | $58 |
| Hydrocodone-Acetaminophen | 155 | $2,021 | $13 |
| Metoprolol | 45 | $1,806 | $40 |
| Tekturna | 15 | $1,734 | $116 |
| Hydralazine | 91 | $1,731 | $19 |
| Benazepril | 204 | $1,573 | $8 |
| Minoxidil | 47 | $1,347 | $29 |
| Metoprolol | 202 | $1,273 | $6 |
| Megestrol Acetate | 21 | $1,065 | $51 |
| Atorvastatin | 61 | $981 | $16 |
| Tamsulosin | 54 | $977 | $18 |
| Furosemide | 177 | $962 | $5 |
| Levofloxacin | 39 | $949 | $24 |
| Simvastatin | 128 | $915 | $7 |
| Carvedilol | 96 | $879 | $9 |
| Doxazosin Mesylate | 73 | $871 | $12 |
| Felodipine Er | 19 | $865 | $46 |
| Bd Ultra-Fine Pen Needle | 20 | $818 | $41 |
| Bumetanide | 48 | $748 | $16 |
| Insulin | 32 | $682 | $21 |
| Potassium Chloride | 21 | $670 | $32 |
| Lisinopril | 115 | $647 | $6 |
| Proair Hfa | 13 | $612 | $47 |
| Metoclopramide | 83 | $612 | $7 |
| Fluconazole | 16 | $582 | $36 |
| Isosorbide Mononitrate Er | 37 | $558 | $15 |
| Levothyroxine | 63 | $531 | $8 |
| Lactulose | 30 | $521 | $17 |
| Prednisone | 76 | $486 | $6 |
| Promethazine | 34 | $474 | $14 |
| Nifedical Xl | 12 | $447 | $37 |
| Fluoxetine | 38 | $404 | $11 |
| Hydrochlorothiazide | 75 | $387 | $5 |
| Clonidine | 38 | $376 | $10 |
| Cartia Xt | 12 | $348 | $29 |
| Ramipril | 33 | $345 | $10 |
| Glipizide | 78 | $339 | $4 |
| Isosorbide Dinitrate | 11 | $336 | $31 |
| Citalopram Hbr | 60 | $323 | $5 |
| Azithromycin | 35 | $320 | $9 |
| Sulfamethoxazole-Trimethoprim | 38 | $305 | $8 |
| Terazosin | 44 | $299 | $7 |
| Calcitriol | 11 | $297 | $27 |
| Zolpidem | 58 | $291 | $5 |
| Famotidine | 27 | $266 | $10 |
| Amox Tr-Potassium Clavulanate | 13 | $255 | $20 |
| Lidocaine-Prilocaine | 11 | $235 | $21 |
| Oxybutynin Chloride | 16 | $233 | $15 |
| Diphenoxylate-Atropine | 22 | $227 | $10 |
| Cephalexin | 32 | $224 | $7 |
| Atenolol | 32 | $205 | $6 |
| Allopurinol | 37 | $198 | $5 |
| Tramadol | 22 | $185 | $8 |
| Lorazepam | 26 | $185 | $7 |
| Alprazolam | 34 | $173 | $5 |
| Pravastatin | 13 | $173 | $13 |
| Enalapril Maleate | 15 | $162 | $11 |
| Paroxetine | 12 | $158 | $13 |
| Lovastatin | 17 | $135 | $8 |
| Amitriptyline | 33 | $124 | $4 |
| Spironolactone | 13 | $105 | $8 |
| Metformin | 15 | $97 | $6 |
| Ranitidine | 12 | $89 | $7 |
| Trazodone | 20 | $60 | $3 |
| Ciprofloxacin | 11 | $52 | $5 |
Money from drug and device companies
$1,216 in 2025
| 2025 | 17 | 64 | None | $1,216 |
| 2024 | 13 | 54 | None | $1,090 |
| 2023 | 16 | 70 | None | $1,292 |
| 2022 | 14 | 85 | None | $1,516 |
| 2021 | 13 | 82 | None | $1,356 |
| 2020 | 12 | 54 | None | $947 |
| 2019 | 13 | 87 | None | $1,412 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Krystexxa | $307 | 23 payments
|
| Travere Therapeutics | None | $224 | 8 payments
|
| GlaxoSmithKline | Benlysta | $103 | 6 payments
|
| Calliditas Therapeutics US | Tarpeyo | $82 | 4 payments
|
| Mallinckrodt Hospital Products | Acthar | $82 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $64 | 3 payments
|
See all 64 published payments
| Calliditas Therapeutics US | Meals · 2025-12-18 | Tarpeyo | $25 |
| GlaxoSmithKline | Meals · 2025-12-10 | Benlysta | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-10 | Kerendia | $20 |
| Amgen | Meals · 2025-12-10 | Krystexxa | $10 |
| Amgen | Meals · 2025-12-03 | Evenity | $6 |
| GlaxoSmithKline | Meals · 2025-11-26 | Benlysta | $17 |
| Amgen | Meals · 2025-11-26 | Krystexxa | $13 |
| Genentech USA | Meals · 2025-11-05 | Gazyva | $29 |
| Amgen | Meals · 2025-11-05 | Krystexxa | $9 |
| Amgen | Meals · 2025-10-22 | Krystexxa | $1 |
| Amgen | Meals · 2025-10-22 | Krystexxa | $9 |
| Amgen | Meals · 2025-10-22 | Krystexxa | $1 |
| Amgen | Meals · 2025-10-01 | Krystexxa | $17 |
| Amgen | Meals · 2025-08-27 | Krystexxa | $12 |
| GlaxoSmithKline | Meals · 2025-08-20 | Benlysta | $15 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Vanrafia | $14 |
| Amgen | Meals · 2025-08-14 | Tavneos | $25 |
| Amgen | Meals · 2025-08-13 | Krystexxa | $7 |
| Calliditas Therapeutics US | Meals · 2025-08-06 | Tarpeyo | $18 |
| Amgen | Meals · 2025-08-04 | Evenity | $23 |
| Novo Nordisk | Meals · 2025-07-31 | Wegovy | $25 |
| Amgen | Meals · 2025-07-30 | Krystexxa | $17 |
| Mallinckrodt Hospital Products | Meals · 2025-07-24 | Acthar | $33 |
| Heron Therapeutics | Meals · 2025-07-21 | Zynrelef | $17 |
| Ardelyx | Meals · 2025-07-21 | Ibsrela | $27 |
| Novartis Pharmaceuticals | Meals · 2025-07-15 | Fabhalta | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-09 | Kerendia | $21 |
| Ardelyx | Meals · 2025-07-09 | Ibsrela | $24 |
| Amgen | Meals · 2025-07-02 | Krystexxa | $17 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-25 | Jardiance | $24 |
| Amgen | Meals · 2025-06-25 | Krystexxa | $11 |
| Calliditas Therapeutics US | Meals · 2025-06-25 | Tarpeyo | $15 |
| GlaxoSmithKline | Meals · 2025-06-18 | Benlysta | $18 |
| Amgen | Meals · 2025-06-04 | Krystexxa | $19 |
| Amgen | Meals · 2025-06-02 | Evenity | $20 |
| GlaxoSmithKline | Meals · 2025-05-21 | Benlysta | $17 |
| Mallinckrodt Hospital Products | Meals · 2025-05-21 | Acthar | $19 |
| Novartis Pharmaceuticals | Meals · 2025-05-07 | None | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-30 | Kerendia | $23 |
| Amgen | Meals · 2025-04-09 | Uplizna | $10 |
| Amgen | Meals · 2025-04-09 | Krystexxa | $17 |
| Travere Therapeutics | Meals · 2025-03-19 | None | $34 |
| Aurinia Pharma U.S. | Meals · 2025-03-19 | Lupkynis | $15 |
| Amgen | Meals · 2025-03-12 | Krystexxa | $11 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-06 | Farxiga | $22 |
| ANI Pharmaceuticals | Meals · 2025-03-06 | Purified Cortrophin Gel | $14 |
| Mallinckrodt Hospital Products | Meals · 2025-03-05 | Acthar | $30 |
| Travere Therapeutics | Meals · 2025-03-05 | None | $24 |
| Fresenius USA Marketing | Meals · 2025-03-04 | Velphoro | $21 |
| Amgen | Meals · 2025-03-03 | Tavneos | $25 |
| Amgen | Meals · 2025-02-26 | Krystexxa | $15 |
| Travere Therapeutics | Meals · 2025-02-26 | None | $31 |
| Novo Nordisk | Meals · 2025-02-20 | None | $25 |
| Travere Therapeutics | Meals · 2025-02-19 | None | $23 |
| Travere Therapeutics | Meals · 2025-02-06 | None | $25 |
| Travere Therapeutics | Meals · 2025-01-31 | None | $37 |
| Fresenius USA Marketing | Meals · 2025-01-30 | Velphoro | $22 |
| Vifor Pharma | Meals · 2025-01-29 | Veltassa | $21 |
| Amgen | Meals · 2025-01-29 | Krystexxa | $13 |
| Travere Therapeutics | Meals · 2025-01-22 | None | $27 |
| Fresenius USA Marketing | Meals · 2025-01-22 | Velphoro | $18 |
| GlaxoSmithKline | Meals · 2025-01-15 | Benlysta | $16 |
| Calliditas Therapeutics US | Meals · 2025-01-15 | Tarpeyo | $24 |
| Travere Therapeutics | Meals · 2025-01-09 | None | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,090
| Fresenius USA Marketing | Velphoro | $386 | 19 payments
|
| Amgen | Aranesp | $255 | 14 payments
|
| Novo Nordisk | Ozempic | $88 | 4 payments
|
| Calliditas Therapeutics US | Tarpeyo | $59 | 3 payments
|
| Travere Therapeutics | None | $54 | 3 payments
|
| Genzyme | Fabrazyme | $46 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $40 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $38 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $34 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $24 | 1 payment
|
| Chiesi USA | Elfabrio | $24 | 1 payment
|
| GlaxoSmithKline | Benlysta | $23 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $19 | 1 payment
|
2023: $1,292
| Travere Therapeutics | None | $264 | 18 payments
|
| Amgen | Epogen | $222 | 12 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $179 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $152 | 7 payments
|
| Aurinia Pharma U.S. | Lupkynis | $92 | 4 payments
|
| Vifor Pharma | Veltassa | $78 | 3 payments
|
| Alexion Pharmaceuticals | Ultomiris | $57 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $54 | 2 payments
|
| Genzyme | Fabrazyme | $41 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $37 | 2 payments
|
| GlaxoSmithKline | Benlysta | $26 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $22 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $20 | 1 payment
|
| Kyowa Kirin | None | $19 | 1 payment
|
| Lilly USA | Jardiance | $17 | 1 payment
|
| Novo Nordisk | Rybelsus | $13 | 1 payment
|
2022: $1,516
| Fresenius USA Marketing | Velphoro | $384 | 23 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $248 | 13 payments
|
| GlaxoSmithKline | Benlysta | $158 | 7 payments
|
| Vifor Pharma | Veltassa | $145 | 11 payments
|
| Amgen | Parsabiv | $113 | 5 payments
|
| Travere Therapeutics | None | $100 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $98 | 5 payments
|
| OPKO Pharmaceuticals | Rayaldee | $74 | 5 payments
|
| Horizon Therapeutics plc | Krystexxa | $68 | 4 payments
|
| Aurinia Pharma U.S. | Lupkynis | $63 | 3 payments
|
| Akebia Therapeutics | Auryxia | $18 | 1 payment
|
| AMAG Pharmaceuticals | Feraheme | $18 | 1 payment
|
| Genzyme | Fabrazyme | $16 | 1 payment
|
| Novo Nordisk | Ozempic | $15 | 1 payment
|
2021: $1,356
| Fresenius USA Marketing | Velphoro | $466 | 30 payments
|
| Vifor Pharma | Veltassa | $139 | 10 payments
|
| OPKO Pharmaceuticals | Rayaldee | $136 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $131 | 8 payments
|
| Amgen | Parsabiv | $124 | 6 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $80 | 4 payments
|
| Aurinia Pharma U.S. | Lupkynis | $72 | 3 payments
|
| GlaxoSmithKline | Benlysta | $64 | 3 payments
|
| Horizon Therapeutics plc | Krystexxa | $47 | 3 payments
|
| Novo Nordisk | Ozempic | $46 | 3 payments
|
| Biogen | None | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
| Abbott Laboratories | Cardiomems Hf System | $13 | 1 payment
|
2020: $947
| Relypsa | Veltassa | $292 | 20 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $198 | 11 payments
|
| Amgen | Parsabiv | $195 | 7 payments
|
| OPKO Pharmaceuticals | Rayaldee | $79 | 5 payments
|
| Horizon Therapeutics plc | Krystexxa | $38 | 2 payments
|
| Alexion Pharmaceuticals | Soliris | $25 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $24 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $22 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $21 | 1 payment
|
| AMAG Pharmaceuticals | Feraheme | $20 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $19 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $14 | 1 payment
|
2019: $1,412
| Relypsa | Veltassa | $321 | 29 payments
|
| Amgen | Aranesp | $280 | 12 payments
|
| Fresenius USA Marketing | Velphoro | $219 | 20 payments
|
| Otsuka America Pharmaceutical | Samsca | $213 | 8 payments
|
| Akebia Therapeutics | Auryxia | $104 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $95 | 5 payments
|
| Mallinckrodt Enterprises | Acthar | $75 | 1 payment
|
| Genzyme | Fabry-Disease | $25 | 1 payment
|
| Janssen Pharmaceuticals | Invokana | $18 | 1 payment
|
| Baxter Healthcare | Renal - Crrt | $17 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $16 | 1 payment
|
| Daiichi Sankyo | Injectafer | $15 | 1 payment
|
| Hikma Pharmaceuticals USA | Mitigare | $14 | 1 payment
|
Professional record
- NPI
- 1447339452
- Licence
- CA A669020
- Trained
- University of Virginia School of Medicine, 1997
- Group
- Central Coast Nephrology Medical Corporation · County of Monterey
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A669020
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 917 Blanco Circle, Salinas, CA, 93901
- NPI first listed
- 2006-11-02
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.